Finally, we performed a comparative evaluation of serum levels of CEA, CA19-9, and albumin, identifying only one statistically significant difference: higher albumin levels in EO-CRC patients compared to LO-CRC patients. This evidence concerns the gene ALB and colorectal carcinoma.